0 CHECKOUT

PRODUCT FILTERS

REGION

632
566
564
550
550

COUNTRY

546
22
15
14
13

PRICE

96
206
362
1,239

PUBLISHED

232
362
662
1,239

PRODUCT TYPE

1,027
94
92
26

Respiratory Drugs

Respiratory drugs is a growing sector of the pharmaceuticals industry, and we have all the information resources that you need to be a leading player in this lucrative market. The publications listed under Research and Markets’ Respiratory Drugs category cover all drugs and therapeutics for conditions and diseases relating to the lungs and/or breathing, such as Acute Respiratory Distress Syndrome (ARDS), allergy, asthma, bronchitis, COPD (chronic obstructive pulmonary disease), cystic fibrosis, emphysema, lung disease, pneumonia, sinus infections, sleep apnea and others.

Our reports, books, and subscriptions will provide you with the latest industry news, forecasts, market trends and company profiles of market leaders and niche players including: Accentia Biopharmaceuticals, Aerogen, Aerovance, airPharma, AstraZeneca, Aventis Pharma, Bespak, Boehringer Ingelheim Pharmaceuticals, Cadila Pharmaceuticals, Dr. Reddys Laboratories, EvoGenix, GlaxoSmithKlineInyx, The Merck Generics Group, Novartis AG, Pfizer, Ranbaxy Laboratories, Respironics, Sandoz International, Schering-Plough, etc.

Publications on smoking cessation are listed under the OTC sub-category in the Pharmaceuticals section. Show Less
Read more

Global Preventive Asthma Drugs Market 2015-2019

About asthma According to the Global Initiative for Asthma, asthma is a chronic disease, which is characterized by wheezing, shortness of breath, chest tightness, and cough over a period of time. The...

Published:  October 2015
Price:  From

Global COPD and Asthma Devices Market - Industry Analysis 2015-2019

About COPD and asthma devices COPD and asthma devices are used for inhalation therapy. These devices convert drug suspensions or solutions into aerosolized particles, assisting in drug delivery in individuals...

Published:  October 2015
Price:  From

Asthma Drugs Market in the US 2015-2019

About asthma Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is...

Published:  June 2015
Price:  From

Global Allergic Rhinitis Drugs Market 2016-2020

About Allergic Rhinitis Drugs Allergic rhinitis is caused by the interaction of airborne allergens with specific immunoglobulin E (IgE) type antibodies on the surface of mast cells. This interaction...

Published:  February 2016
Price:  From

Orally Inhaled Bronchodilators to 2022

Asthma and COPD continue to be a health segments that present significant challenges to patients and the caregiver community. Patient adherence with prescribing instructions and treatment protocols...

Published:  April 2015
Price:  From

Detailed assessment of CIPLA in Indian Respiratory (Asthma & COPD) Market

Established in 1935, Cipla diversified into respiratory business segment in 1972 with launch of medicinal aerosols. At present, Cipla is one of the largest players in Indian respiratory market with...

Published:  March 2015
Price:  From

Amoxicillin (CAS 61336-70-7) Market Research Report 2016

This Global Report 2016 is a result of industry experts’ diligent work on researching the world market of amoxicillin. The report helps to build up a clear view of the market (trends and prospects),...

Published:  March 2016
Price: 

2016-2020 US Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

About This Report This new 283-page report from the publisher presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza,...

Published:  March 2016
Price:  From

2015-2019 US Respiratory Disease Market: Emerging Opportunities for Suppliers--Competitive Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review

About This Report This new 283-page report presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis,...

Published:  July 2015
Price:  From

2016-2020 Japan Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

About This Report This new 282-page report from the publisher presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus,...

Published:  March 2016
Price:  From

Global COPD and Asthma Devices Market (Product Types and Geography) - Size, Share, Global Trends, Company Profiles, Analysis, Segmentation and Forecast, 2013 - 2020

The COPD and Asthma hold the largest market share within the global respiratory diseases’ market. As estimated by Global Initiative for Asthma (GINA), approximately 300 million people suffer from Asthma...

Published:  November 2014
Price:  From

Inhaled COPD Therapeutics

COPD is not one but a family of conditions, each with its own etiology and treatment challenges Chronic bronchitis is the inflammation and eventual scarring of the lining of the bronchial tubes Oral...

Published:  June 2014
Price:  From

Inhaled Asthma Therapeutics

Asthma continues to be a health segment with significant incidence and morbidity There has been significant interest directed toward the development easier-to-use inhalers, primarily because a large...

Published:  June 2014
Price:  From

Global Chronic Obstructive Pulmonary Disease (COPD) Market 2014-2018

About COPD COPD is a broad term that covers various progressive lung diseases including emphysema, chronic bronchitis, refractory (non-reversible) asthma, and some forms of bronchiectasis. It is a...

Published:  October 2014
Price:  From

COPD Drug Market Opportunity & Clinical Pipeline Analysis

Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the...

Published:  April 2014
Price:  From

2016-2020 World Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

About this Report This new 366-page report from the publisher presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current...

Published:  March 2016
Price:  From

2016-2020 Spain Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

About This Report This new 281-page report from the publisher presents detailed analysis of the Spanish Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus,...

Published:  March 2016
Price:  From

2016-2020 Germany Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

About This Report This new 283-page report from the publisher presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza,...

Published:  March 2016
Price:  From

2016-2020 France Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

About This Report This new 282-page report from the publisher presents detailed analysis of the French Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza,...

Published:  March 2016
Price:  From

2016-2020 Italy Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

About This Report This new 281-page report from the publisher presents detailed analysis of the Italian Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus,...

Published:  March 2016
Price:  From
Loading Indicator

Our Clients